Details of proposals by the life sciences sector to build the UK’s status as a world-leader were unveiled today (Wednesday 30 August), with a breakdown of how the £160 million of funding will support the sector.
The strategy outlines the vision for how government can work alongside the sector to boost businesses large and small across the £64 billion life sciences industry.
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said:
“The unveiling of the Government’s blueprint for building a burgeoning life sciences sector as we prepare to leave the EU, and for driving real progress for breast cancer patients, is immensely positive.
“Following today’s promised £160million investment, we now urge the Government to implement the report’s recommendations as quickly as possible to ensure the UK continues to thrive as a world-leader in life sciences.
“Crucially, we look forward to this strategy driving much-needed improvements in patient outcomes, and to seeing a strong deal between Government and the sector in the coming months to ensure further investment.
“In particular, we’re pleased to see this report pushing for greater collaboration between the NHS and the pharmaceutical industry, as well as the adoption of recommendations from the Accelerated Access Review, an increase to the Charity Research Support Fund, and using patient data more effectively to improve healthcare.
“We remain very concerned about the budget impact test introduced by NHS England and NICE earlier this year, which could delay patient access to innovative treatments and therefore runs counter to the ambitions of the Strategy. We, alongside many other charities, remain ready and willing to work with all involved to look at how this critical issue can be resolved for patients.”